Nov 3, 2014 | Digital Pathology, Instruments & Equipment, Laboratory Instruments & Laboratory Equipment, Laboratory Management and Operations, Laboratory News, Laboratory Operations, Laboratory Pathology
Researchers at Israel’s Bar-Ilan University attract attention with their unique assay that detects cancers of the tongue and the larynx
Researchers in Israel developed a non-invasive oral test for cancers of the tongue and larynx that uses gold nanoparticles and antibodies to “paint” cancer cells. An imaging tool then allows physicians to identify any tumor cells that may be present.
This demonstration of how the combination of gold nanoparticles and antibodies can detect cancer may form the basis for a new approach that enables in vitro diagnostics manufacturers and pathologists to develop medical laboratory tests that can non-invasively identify different types of cancers.
This nanotechnology-based cancer diagnostic method was created by scientists at Bar-Ilan University (BIU) Ramat Gan, Tel Aviv District of Israel. Researchers conducted successful tests of this technology on animals and “recently proved itself during its first tests on humans,” according to a news story in the Israeli daily Haaretz. (more…)
Oct 20, 2010 | Laboratory News, Laboratory Pathology
Company will develop solutions for new reimbursement models, evidence-based care, and supporting health service delivery needs
Earlier this fall, IBM Corporation (NYSE: IBM) announced plans to invest $100 million specifically to advance IBM capabilities in three key areas of healthcare informatics. That seemed like a big deal that might affect clinical pathology, since IBM is one of the information technology (IT) giants in the United States.
However, Dark Daily editors made a surprising discovery as they researched the news of IBM’s new $100 million healthcare IT investment initiative. IBM has a habit of making $100 million investments in recent years! It has learned that dropping a press release that announces a $100 million IT investment initiative generates plenty of press coverage.
(more…)
Dec 4, 2009 | Laboratory News, Laboratory Pathology
Nano-technology Breakthrough May Prevent Cancers from Metastasizing
With the goal of removing tumor cells from the bloodstream, a biomedical engineering team at the University of Arkansas for Medical Sciences (UAMS) in Little Rock has discovered a non-invasive way to identify cancer and to capture tumor cells in the bloodstream. This landmark discovery, could dramatically improve early cancer diagnosis and prevent deadly metastasis. It could also provide a framework for a new type of diagnostic test that could detect metastatic cancer from a blood sample.
(more…)
